Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-21

Clinical Trial Update: Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic [NA]

View source ↗

Summary

Completed clinical trial evaluating Reward Re-Training for reward imbalance in bulimia nervosa and related eating disorders; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Drexel University | Conditions: Bulimia Nervosa, Bulimia; Atypical | NA | Status: COMPLETED | Results posted: 2024-03-21